メタ情報
| meta description平均長 | 0 |
|---|
| OGPありページ数 | 0 |
|---|
| Twitterカードありページ数 | 0 |
|---|
文字コード 分布
| キー | 割合 |
|---|
| shift_jis | 90.00% |
| utf-8 | 5.00% |
| euc-jp | 5.00% |
内部リンク分析(Internal)
| ユニーク内部リンク数 | 64 |
|---|
| ページあたり内部リンク平均 | 12.8 |
|---|
連絡先候補(Contacts)
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| small | 1 |
| cell | 1 |
| lung | 1 |
| cancer | 0.971429 |
| non | 0.914286 |
| doi | 0.8 |
| UMIN | 0.8 |
| Cancer | 0.70274 |
| study | 0.658819 |
| patients | 0.628571 |
| Lung | 0.514286 |
| plus | 0.514286 |
| PDF | 0.514286 |
| Oncology | 0.488526 |
| org | 0.395291 |
| Phase | 0.373331 |
| phase | 0.371429 |
| advanced | 0.371429 |
| Thoracic | 0.35137 |
| Research | 0.35137 |
| https | 0.329409 |
| EGFR | 0.325684 |
| Ikeda | 0.314286 |
| http | 0.307449 |
| jRCT | 0.307449 |
| F00 | 0.289497 |
| Kato | 0.285714 |
| Study | 0.285488 |
| Journal | 0.263527 |
| cisplatin | 0.257143 |
| www | 0.241567 |
| Non | 0.228571 |
| Cell | 0.228571 |
| carboplatin | 0.228571 |
| docetaxel | 0.228571 |
| bevacizumab | 0.228571 |
| Group | 0.219606 |
| trial | 0.219606 |
| Clinical | 0.217123 |
| chemotherapy | 0.2 |
| treatment | 0.2 |
| elderly | 0.2 |
| Protocol | 0.2 |
| Small | 0.171429 |
| squamous | 0.171429 |
| BMC | 0.171429 |
| N11 | 0.162842 |
| III | 0.162842 |
| N9 | 0.158659 |
| line | 0.153724 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| cell | lung | 3.925524 | 135 |
| cancer | lung | 3.886223 | 132 |
| cell | small | 3.831815 | 132 |
| non | small | 3.489983 | 112 |
| http | www | 3.399548 | 42 |
| Group | Research | 2.904343 | 41 |
| F2026 | j19 | 2.893302 | 20 |
| Cancer | Lung | 2.85904 | 70 |
| F00 | j19 | 2.825814 | 24 |
| doi | org | 2.765519 | 64 |
| cancer | cell | 2.741213 | 96 |
| lung | small | 2.69586 | 96 |
| Cell | Small | 2.67075 | 24 |
| Ikeda | Kato | 2.637814 | 32 |
| F00 | F2026 | 2.591947 | 20 |
| cell | non | 2.553163 | 84 |
| doi | https | 2.540174 | 54 |
| Oncology | Thoracic | 2.455201 | 52 |
| previously | treated | 2.431017 | 16 |
| https | org | 2.415457 | 42 |
| Cell | Lung | 2.413415 | 32 |
| fibrosis | pulmonary | 2.336164 | 12 |
| completely | resected | 2.336164 | 12 |
| oncology | research | 2.336164 | 12 |
| group | research | 2.336164 | 12 |
| article | related | 2.336164 | 12 |
| N9 | PDF | 2.301877 | 22 |
| Non | Small | 2.300014 | 20 |
| docetaxel | plus | 2.258024 | 29 |
| advanced | non | 2.257006 | 46 |
| Asia | SCRUM | 2.242309 | 10 |
| Cell | Non | 2.194626 | 21 |
| CD3 | DLL3 | 2.169405 | 9 |
| N2 | PDF | 2.150423 | 14 |
| Quality | life | 2.022917 | 10 |
| Epidermal | Uncommon | 2.01593 | 8 |
| Epidermal | Growth | 2.01593 | 8 |
| Factor | Growth | 2.01593 | 8 |
| Factor | Receptor | 2.01593 | 8 |
| Mutations | Receptor | 2.01593 | 8 |
| ACHILLES | Mutations | 2.01593 | 8 |
| Induced | Pneumonitis | 2.01593 | 8 |
| Investigational | New | 2.01593 | 8 |
| Drugs | New | 2.01593 | 8 |
| Drugs | published | 2.01593 | 8 |
| online | published | 2.01593 | 8 |
| aged | years | 2.01593 | 8 |
| Advances | Therapeutic | 2.01593 | 8 |
| atezolizumab | pretreated | 2.01593 | 8 |
| interstitial | pneumonias | 2.01593 | 8 |